Alpine Fox Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Alpine Fox Capital's REGN Position: Q2 2026 in Review
Alpine Fox Capital reduced its Regeneron Pharmaceuticals (REGN) stake by 50% in Q2 2026, selling an estimated $340K and leaving 500 shares worth $312K. The position accounts for 0.15% of the portfolio, ranked #14.
Alpine Fox Capital first reported a position in REGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $773K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Alpine Fox Capital held 500 shares of Regeneron Pharmaceuticals worth $312K as of Q2 2026.
- Alpine Fox Capital sold 500 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $340K.
- Regeneron Pharmaceuticals made up 0.15% of Alpine Fox Capital's portfolio in Q2 2026, its #14 holding.
- Alpine Fox Capital first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- Alpine Fox Capital's Regeneron Pharmaceuticals position peaked at $773K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Alpine Fox Capital's 13F filing for Q2 2026, filed 14 Aug 2026.